A Bucks County woman is speaking out after her insurance company decided to no longer cover weight loss drugs.
Zyn nicotine pouches loved by young people for their appetite-suppressing effects have officially been approved in the US.
Zepbound is a dual-activating medication that combines glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like ...
In one corner, we’ve got Mounjaro, and in the other, Ozempic. They’re both once-a-week injectable drugs designed to help ...
Current laws and regulations are not enough to protect Americans from the risks of compounded versions of popular weight loss ...
Pharmaceutical giants Eli Lilly and Novo Nordisk, makers of Zepbound and Wegovy, respectively, have filed lawsuits against medical spas, weight-loss clinics, and compounding pharmacies they accuse of ...
Some people are microdosing certain weight loss drugs in an attempt to reap some of the drugs' benefits with fewer of their side effects. But doctors specializing in weight loss say that ...
Eli Lilly & Co. ( LLY) thinks its next experimental weight-loss pill could get approved as soon as early 2026.
Also in today’s edition: ‘no-show’ international student data and significant progress in Israel-Hamas ceasefire talks ...
The Biden administration on Friday released the next round of prescription drugs selected for Medicare price negotiations, ...
Ozempic, an anti-diabetes medication, has gained popularity for its off-label use in weight loss among celebrities, despite ...